Albert Einstein College of Medicine (Einstein) is a graduate school of Yeshiva University. It is a not-for-profit, private, nonsectarian medical school located on the Jack and Pearl Resnick Campus in the Morris Park neighborhood of the borough of the Bronx of New York City. In addition to medical degrees, Einstein offers graduate biomedical degrees through the Sue Golding Graduate Division. Allen M. Spiegel, M.D., has served as The Marilyn and Stanley M. Katz Dean since June 1, 2006.
Einstein main focal areas are medical education, basic research, and clinical investigation. During the 2011-2012 academic year, Einstein is home to 2,522 full-time faculty members, 724 M.D. students, 248 Ph.D. students attending the Sue Golding Graduate Division and 117 students in the combined M.D./Ph.D. program. In addition, there are 368 postdoctoral research fellows at the Belfer Institute for Advanced Biomedical Studies.
The medical school is known for its humanistic approach to its curriculum and training and for the diversity of its student body. The class of 2015 includes 183 students from 27 different U.S. states, 32 students born outside the U.S., and 23 students who identify themselves as belonging to groups considered underrepresented in medicine.
Einstein is also a major biomedical and clinical research facility. Faculty members received nearly $170 million in funding from the National Institutes of Health in 2011, ranking 23rd among U.S. medical schools. In addition, the NIH funds major research centers at Einstein in diabetes, cancer, liver disease, and AIDS.
The Mission of Albert Einstein College of Medicine is to prepare physicians and researchers to excel in the science and the art of medicine and basic, translational and clinical investigation. Its founding mandate is to combine the pursuit of scientific excellence with a social mission to improve human health through engagement in local, national and global communities.
In 1964, Einstein was the first medical school in the United States to establish a Department of Genetics.
In 1965, Einstein opened one of the first General Clinical Research Centers in the US, funded by the NIH.
In 1974, Einstein's Liver Research Center now the Marion Bessin Liver Research Center was the first institute in the nation devoted to the study of liver disease and injury.
In 1976, researchers at Einstein identified the mechanism of action of Taxol, one of the most significant cancer-treatment drugs ever developed. (Susan B. Horwitz, Ph.D.)
In 1978, Einstein was designated a Diabetes Research and Training Center, one of 7 such comprehensive centers in the US. The Center has been home to a who's-who of diabetes investigators involved in seminal work on the insulin receptor, the mechanism of diabetes complications, on glucose toxicity, on brain control of metabolism, and on hypoglycemia as well as landmark studies such as the Diabetes Control and Complications Trial and the Diabetes Prevention Program.
In 1988, one of the first NIH-funded Centers for AIDS Research (CFARs) in the country was created at Einstein. Researchers at the center were the first to identify pediatric AIDS as a distinct disease and established the first day-care center in the world for children with AIDS. (Arye Rubinstein, M.D.)
In 1994, Einstein became the only New York City medical school selected by the NIH to participate in the Women's Health Initiative, the largest research study of women's health ever undertaken. (Sylvia Wassertheil-Smoller, Ph.D., principal investigator)
In 2006, Einstein became the only medical institution in the Northeast to serve as a research site for the Hispanic Community Health Study, the largest research study of Hispanic health ever conducted. (Sylvia Wassertheil-Smoller, Ph.D., principal investigator)
Einstein researchers demonstrated the association between reduced levels of high-density lipoproteins (HDL), or "good" cholesterol, and heart disease.
Einstein researchers identified a key missing neurotransmitter in the brains of patients with Alzheimer's disease, a finding that influenced all subsequent Alzheimer's disease research. (Peter Davies, Ph.D.)
Researchers at Einstein discovered structural abnormalities of brain cells that explain deficiencies in cognitive development, greatly contributing to our understanding of mental retardation. (Dominick P. Purpura, M.D.)
Einstein researchers helped discover the mechanisms responsible for the extraordinary diversity of antibodies and their remarkable precision in mounting an immune response. (Matthew D. Scharff, M.D.)
Scientists at Einstein pioneered research that has led to improved methods of avoiding organ transplant rejection. (Stanley G. Nathenson, M.D.)
Einstein researchers are leaders in epidemiologic research in migraine and other types of headache. (Richard B. Lipton, M.D.)
Choosing Albert Einstein College of Medicine
Medical students at Albert Einstein College of Medicine share their compelling reasons for attending Einstein. Tops on their list: Einstein's collaborative environment, opportunities to practice community and global medicine, outstanding research and academic programs, and innovative class structure. In this video, you'll see Einstein's spacious campus and the surrounding Morris Park neighborhood - all just 30 minutes from Manhattan.
Subscribe to the subject Albert Einstein College of Medicine